Although IL-23R KO mice had reduced inflammation (lower levels of IL-17 among other inflammatory cytokines) in the stage of premalignant lesions, conversion to the inhibitory phenotype of inflammatory cells (IL-10 producing) in the stage of oral cancer lacked inflammation. The gene discussed is IL17A; the disease is lip and oral cavity carcinoma.